C07F 9/6512
Having the nitrogen atoms in positions 1 and 3
Official title: having the nitrogen atoms in positions 1 and 3
C07F9/6512 (Having the nitrogen atoms in positions 1 and 3) appears on 477 US grants and 342 published applications in this corpus.
Search patents in C07F- Granted patents
- 477
- Published applications
- 342
- Assignees
- 266
- Inventors
- 1,178
- Latest grant
- 8 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 7 | 0 |
| 1977 | 10 | 0 |
| 1978 | 8 | 0 |
| 1979 | 6 | 0 |
| 1980 | 5 | 0 |
| 1981 | 7 | 0 |
| 1982 | 9 | 0 |
| 1983 | 6 | 0 |
| 1984 | 7 | 0 |
| 1985 | 8 | 0 |
| 1986 | 6 | 0 |
| 1987 | 10 | 0 |
| 1988 | 10 | 0 |
| 1989 | 9 | 0 |
| 1990 | 6 | 0 |
| 1991 | 10 | 0 |
| 1992 | 7 | 0 |
| 1993 | 10 | 0 |
| 1994 | 11 | 0 |
| 1995 | 12 | 0 |
| 1996 | 7 | 0 |
| 1997 | 20 | 0 |
| 1998 | 21 | 0 |
| 1999 | 11 | 0 |
| 2000 | 9 | 0 |
| 2001 | 5 | 3 |
| 2002 | 9 | 6 |
| 2003 | 2 | 13 |
| 2004 | 8 | 17 |
| 2005 | 2 | 14 |
| 2006 | 7 | 12 |
| 2007 | 11 | 12 |
| 2008 | 7 | 15 |
| 2009 | 10 | 13 |
| 2010 | 8 | 8 |
| 2011 | 8 | 7 |
| 2012 | 11 | 16 |
| 2013 | 6 | 17 |
| 2014 | 13 | 22 |
| 2015 | 21 | 18 |
| 2016 | 17 | 20 |
| 2017 | 16 | 23 |
| 2018 | 18 | 15 |
| 2019 | 12 | 12 |
| 2020 | 8 | 16 |
| 2021 | 13 | 10 |
| 2022 | 4 | 12 |
| 2023 | 11 | 15 |
| 2024 | 8 | 14 |
| 2025 | 6 | 7 |
| 2026 | 4 | 5 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Prodrugs for sustained releasing therapeutic agents and uses thereof8 Sep 2026US 12,729,186 B2Liangjiang Medicine Co., Ltd.
- 5′-modified carbocyclic ribonucleotide derivatives and methods of use26 May 2026US 12,636,301 B2Sanegene Bio USA Inc.
- Promoiety strategy to enhance drug activity12 May 2026US 12,624,058 B2University of Southern California
- SOS1 inhibitor containing phosphorus3 Mar 2026US 12,565,511 B2Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
- Heterocyclic compound and organic light-emitting device comprising same16 Sep 2025US 12,415,823 B2Lt Materials Co., Ltd.
- Quinazoline derivatives as ectonucleotide pyrophosphatase phosphodiesterase 1 inhibitors27 Aug 2026US 2026/0250304 A1Riboscience LLC
- Triple kinase inhibitors26 Mar 2026US 2026/0085050 A1
- Novel benfotiamine choline salt5 Mar 2026US 2026/0062432 A1Rexpharmtech Co., Ltd
- Small molecule compounds with phosphorylated aryl structures and use thereof26 Feb 2026US 2026/0055126 A1Hangzhou PhecdaMed Co., Ltd.
- Aryl hydrocarbon receptor agonists and uses thereof22 Jan 2026US 2026/0022099 A1Nexys Therapeutics, Inc.
Most cited
By later US patents
- Carbocyclic nucleosides containing bicyclic rings, oligonucleotides therefrom, process for their preparation, their use and intermediates468US 5,700,920 ANovartis AG · 1997
- Carbocyclic nucleosides containing bicyclic rings, oligonucleotides therefrom, process for their preparation, their use and intermediates409US 5,610,300 ACiba-Geigy Corporation · 1997
- Alkynylamino-nucleotides340US 5,047,519 AE. I. Du Pont de Nemours and Company · 1991
- Alkynylamino-nucleotides225US 5,151,507 AE. I. Du Pont de Nemours and Company · 1992
- Method, system and reagents for DNA sequencing192US 5,332,666 AE. I. Du Pont de Nemours and Company · 1994